Proposed changes to draft patent law further strengthen incentives to bring new drugs to China

Published date09 July 2020
Subject MatterPatented Medicines,Pharmaceutical Patents,Prescription Drugs,China,Amended Rules,Hatch-Waxman,Public Comment,Patent Term Extensions,Patents
AuthorZhen Feng,Xin Tao,Philip Katz
Law FirmHogan Lovells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT